Biomarker and Diagnostics Strategy

This is where precision medicine starts – whether you’re trying to find the right tools to uncover new biomarkers, identify CDx partners, launch an IVD, or understand how your assay will fit into the clinical journey, DeciBio has you covered. Nobody knows biomarkers and CDx better than DeciBio.

Our Experts

Andrew Aijian

Stephane Budel

David Cavanaugh

David Cavanaugh

Schedule a Call

Related Client Results

All Client Results

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

Voice-of-Customer Research

Pharma & Biotech

Clinical, Genomic, and Pathology Real-World Data (RWD) Market Landscape Assessment

A real-world data (RWD) provider wanted to identify key use cases, unmet needs, and future opportunities in the RWD market, with a particular focus on clinical, genomic, and pathology RWD and biopharma users.

Voice-of-Customer Research

Pricing Strategy

Competitive Analysis

Pharma & Biotech

Cell Therapy Market Trends and Revenue Forecast

DeciBio conducted financial projections, valuation, and assisted with messaging to aid client's public listing to NASDAQ

Revenue Projection

Clinical Diagnostics

Infectious Pathogen Diagnostics Technology Commercialization

A major diagnostics manufacturer had developed a novel technology for the rapid detection of infectious pathogens and required assistance in developing commercialization strategy and sales tactics. DeciBio’s services were contracted to profile relevant stakeholders, characterize existing workflows and acquisition / implementation processes, and develop a product-specific launch strategy.

Voice-of-Customer Research

Clinical Diagnostics

Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing

A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution

Customer Segmentation

Voice-of-Customer Research

Market Landscaping and Sizing

Pre-due Diligence Research on a Potential Acquisition Target

A multi-billion dollar life science company needed pre diligence on a potential acquisition target

Competitive Analysis

Due Diligence

Target Identification

Precision Medicine is evolving at a rapid pace

Discover how we can help